BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 15234236)

  • 1. Human chorionic gonadotropin in cancer.
    Stenman UH; Alfthan H; Hotakainen K
    Clin Biochem; 2004 Jul; 37(7):549-61. PubMed ID: 15234236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
    Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
    Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of HCG and hCG beta determinations.
    Mann K; Saller B; Hoermann R
    Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of human chorionic gonadotropin and alpha-subunit measurements.
    Hussa RO
    Obstet Gynecol; 1982 Jul; 60(1):1-12. PubMed ID: 6283446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of human chorionic gonadotropin.
    Stenman UH; Alfthan H
    Best Pract Res Clin Endocrinol Metab; 2013 Dec; 27(6):783-93. PubMed ID: 24275190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors.
    Harvey RA; Mitchell HD; Stenman UH; Blankenstein MA; Nustad K; Stieber P; Stewart W; Savage PM; Seckl MJ; Braunstein GD
    J Reprod Med; 2010; 55(7-8):285-95. PubMed ID: 20795340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin beta subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma.
    Massart C; Lucas C; Rioux-Leclercq N; Fergelot P; Pouvreau-Quillien V; Volatron AC
    Clin Chem Lab Med; 2005; 43(8):886-9. PubMed ID: 16217885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
    Nisselbaum JS; Bosl GJ; Golbey RB; Schwartz DC; Schwartz MK
    Ann Clin Lab Sci; 1984; 14(3):179-88. PubMed ID: 6203466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of beta-human chorionic gonadotropin expressing cells by nested reverse transcriptase-polymerase chain reaction in the peripheral blood stem cells of patients with advanced germ cell tumor.
    Hara I; Yamada Y; Miyake H; Hara S; Gotoh A; Fujisawa M; Okada H; Arakawa S; Kamidono S
    J Urol; 2002 Mar; 167(3):1487-91. PubMed ID: 11832775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
    Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
    Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA; Kohorn EI; Kim GS
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors.
    Hoermann R; Gerbes AL; Spoettl G; Jüngst D; Mann K
    Cancer Res; 1992 Mar; 52(6):1520-4. PubMed ID: 1540961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Morris MJ; Bosl GJ
    J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives.
    Berger P; Sturgeon C; Bidart JM; Paus E; Gerth R; Niang M; Bristow A; Birken S; Stenman UH
    Tumour Biol; 2002; 23(1):1-38. PubMed ID: 11893904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-seminomatous germ cell tumors of the testis. Immunohistochemical localization and serum levels of human chorionic gonadotropin (HCG) and pregnancy-specific beta-1 glycoprotein (SP-1); value of SP-1 as a tumor marker.
    Suurmeijer AJ; De Bruijn HW; Oosterhuis JW; Sleyfer DT; Koops HS; Fleuren GJ
    Oncodev Biol Med; 1982; 3(5-6):409-22. PubMed ID: 6292873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.